New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 2, 2014
08:05 EDTPCYCPharmacyclics reports Q1 EPS 23c, consensus 17c
Reports Q1 adjusted EPS 40c, compared to 40c a year ago. Reports Q1 revenue $119.4M, consensus $105.38M
News For PCYC From The Last 14 Days
Check below for free stories on PCYC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 25, 2014
08:54 EDTPCYCEMA issues positive opinion, recommends approval of Imbruvica
Subscribe for More Information
July 23, 2014
14:32 EDTPCYCPharmacyclics estimates raised ahead of Q2 report at Goldman
Goldman raised Pharmacyclics' Q2 Imbruvica US sales estimate to $93M from $82M, vs. consensus of $88M and 2014 to $409M from $383M based on IMS data. The firm rates shares a Buy with a $162 price target.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use